These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12853838)

  • 21. Frequent methylation of p16INK4A/p14ARF promoters in tumorigenesis of Epstein-Barr virus transformed lymphoblastoid cell lines.
    Nagy E; Veress G; Szarka K; Csoma E; Beck Z
    Anticancer Res; 2005; 25(3B):2153-60. PubMed ID: 16158958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancer.
    Berggren de Verdier PJ; Kumar R; Adolfsson J; Larsson P; Norming U; Onelöv E; Wijkström H; Steineck G; Hemminki K
    Scand J Urol Nephrol; 2006; 40(5):363-9. PubMed ID: 17060081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients.
    Domínguez G; Carballido J; Silva J; Silva JM; García JM; Menéndez J; Provencio M; España P; Bonilla F
    Clin Cancer Res; 2002 Apr; 8(4):980-5. PubMed ID: 11948103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.
    Wolter M; Reifenberger J; Blaschke B; Ichimura K; Schmidt EE; Collins VP; Reifenberger G
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1170-80. PubMed ID: 11764089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Imazeki F; Tada M; Mikata R; Miyazaki M; Ochiai T; Saisho H
    Liver Int; 2005 Dec; 25(6):1209-16. PubMed ID: 16343074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer.
    Silva J; Domínguez G; Silva JM; García JM; Gallego I; Corbacho C; Provencio M; España P; Bonilla F
    Oncogene; 2001 Jul; 20(33):4586-90. PubMed ID: 11494155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
    Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
    Brenner AJ; Paladugu A; Wang H; Olopade OI; Dreyling MH; Aldaz CM
    Clin Cancer Res; 1996 Dec; 2(12):1993-8. PubMed ID: 9816158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma.
    Uenogawa K; Hatta Y; Arima N; Hayakawa S; Sawada U; Aizawa S; Yamamoto T; Takeuchi J
    Int J Mol Med; 2011 Nov; 28(5):835-9. PubMed ID: 21785817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, an Rb.
    Gerdes B; Ramaswamy A; Ziegler A; Lang SA; Kersting M; Baumann R; Wild A; Moll R; Rothmund M; Bartsch DK
    Ann Surg; 2002 Jan; 235(1):51-9. PubMed ID: 11753042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of the p16 and p15 genes in human bladder tumors.
    Orlow I; Lacombe L; Hannon GJ; Serrano M; Pellicer I; Dalbagni G; Reuter VE; Zhang ZF; Beach D; Cordon-Cardo C
    J Natl Cancer Inst; 1995 Oct; 87(20):1524-9. PubMed ID: 7563186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53.
    Lindström MS; Klangby U; Wiman KG
    Oncogene; 2001 Apr; 20(17):2171-7. PubMed ID: 11360201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and epigenetic alterations of 9p21 gene products in benign and malignant tumors of the head and neck.
    Weber A; Wittekind C; Tannapfel A
    Pathol Res Pract; 2003; 199(6):391-7. PubMed ID: 12924439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.
    Kiss NB; Geli J; Lundberg F; Avci C; Velazquez-Fernandez D; Hashemi J; Weber G; Höög A; Ekström TJ; Bäckdahl M; Larsson C
    Endocr Relat Cancer; 2008 Jun; 15(2):609-21. PubMed ID: 18509008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
    Perrone F; Tamborini E; Dagrada GP; Colombo F; Bonadiman L; Albertini V; Lagonigro MS; Gabanti E; Caramuta S; Greco A; Torre GD; Gronchi A; Pierotti MA; Pilotti S
    Cancer; 2005 Jul; 104(1):159-69. PubMed ID: 15929122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
    Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
    Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
    Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
    J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FBXL16 is a novel E2F1-regulated gene commonly upregulated in p16INK4A- and p14ARF-silenced HeLa cells.
    Sato K; Kusama Y; Tategu M; Yoshida K
    Int J Oncol; 2010 Feb; 36(2):479-90. PubMed ID: 20043084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of the p16INK4a/p14ARF pathway in clear cell sarcoma.
    Takahira T; Oda Y; Tamiya S; Yamamoto H; Kawaguchi K; Kobayashi C; Iwamoto Y; Tsuneyoshi M
    Cancer Sci; 2004 Aug; 95(8):651-5. PubMed ID: 15298727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas.
    Papp T; Schipper H; Pemsel H; Bastrop R; Muller KM; Wiethege T; Weiss DG; Dopp E; Schiffmann D; Rahman Q
    Int J Oncol; 2001 Feb; 18(2):425-33. PubMed ID: 11172613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.